PEAK6 Group’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6 Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$4.58M	Buy	82,852 +32,903	+66%	+$1.78M	0.02%	818
2018 Q1	$3.16M	Buy	49,949 +45,813	+1,108%	+$2.95M	0.01%	1085
2017 Q4	$253K	Buy	+4,136	New	+$259K	﹤0.01%	3000
2017 Q3	–	Sell	-6,450	Closed	-$377K	–	4405
2017 Q2	$359K	Sell	6,450 -119,961	-95%	-$6.53M	﹤0.01%	2830
2017 Q1	$6.87M	Sell	126,411 -80,419	-39%	-$4.41M	0.06%	427
2016 Q4	$12.1M	Buy	206,830 +90,181	+77%	+$4.93M	0.09%	287
2016 Q3	$6.29M	Buy	+116,649	New	+$7.49M	0.05%	566
2016 Q2	–	Sell	-17,421	Closed	-$1.23M	–	4300
2016 Q1	$1.11M	Buy	+17,421	New	+$1.1M	0.01%	1575
2014 Q3	–	Sell	-43,344	Closed	-$2.17M	–	4683
2014 Q2	$2.1M	Buy	43,344 +25,264	+140%	+$1.24M	0.02%	1038
2014 Q1	$939K	Buy	18,080 +6,269	+53%	+$334K	0.01%	1923
2013 Q4	$627K	Sell	11,811 -23,164	-66%	-$1.18M	﹤0.01%	2476
2013 Q3	$1.62M	Buy	+34,975	New	+$1.54M	0.01%	1720

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PEAK6 Group's BMY Position: Q2 2018 in Review

PEAK6 Group increased its Bristol-Myers Squibb (BMY) stake by 66% in Q2 2018, buying an estimated $1.78M and bringing the position to 82,852 shares worth $4.58M. The position accounts for 0.02% of the portfolio, ranked #818.

PEAK6 Group first reported a position in BMY in Q3 2013 and has held it in 12 quarters since. The position peaked at $12.1M in Q4 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

PEAK6 Group held 82,852 shares of Bristol-Myers Squibb worth $4.58M as of Q2 2018.
PEAK6 Group bought 32,903 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.78M.
Bristol-Myers Squibb made up 0.02% of PEAK6 Group's portfolio in Q2 2018, its #818 holding.
PEAK6 Group first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 12 quarters since.
PEAK6 Group's Bristol-Myers Squibb position peaked at $12.1M in Q4 2016.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.